🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrot...
Status
Active Not Recruiting
Location
ProofPilot (Remote Virtual Trial)
Start Date
2020-10-15
Trial ID
NCT04751864
Treatments Being Tested
The purpose of this research study is to determine whether Nexalin Trans-cr...
Status
Active Not Recruiting
Location
Carrier Clinic
Start Date
2018-06-11
Trial ID
NCT03540745
Treatments Being Tested
The purpose of this study is to assess the feasibility and effectiveness of...
Status
Completed
Location
Tripler Army Medical Center
Start Date
2014-02
Trial ID
NCT02419014
Treatments Being Tested
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrot...
Status
Active Not Recruiting
Location
ProofPilot (Remote Virtual Trial)
Start Date
2020-10-01
Trial ID
NCT04627480
Treatments Being Tested
Document whether the Fischer Wallace Cranial Stimulator produces any measur...
Status
Completed
Location
McLean Hospital
Start Date
2010-05
Trial ID
NCT01860677
Treatments Being Tested
This study will examine the effect of cranial electrotherapy stimulation (C...
Status
Terminated
Location
Oxford Brooke University
Start Date
2021-07-05
Trial ID
NCT04587531
Treatments Being Tested
The study aimed to investigate whether cranial electrotherapy stimulation(C...
Status
Terminated
Location
Kaohsiung Veterans General Hospital.
Start Date
2021-02-19
Trial ID
NCT04465136
The purpose of this research study is to determine whether Nexalin Trans-Cr...
Status
Completed
Location
Carrier Clinic
Start Date
2017-09-01
Trial ID
NCT03277846
Treatments Being Tested
Efficacy of Cranial Electrotherapy Stimulation (CES) for the treatment of M...
Status
Terminated
Location
Advanced Psychotherapeutics
Start Date
2017-06-05
Trial ID
NCT03222752
Treatments Being Tested